Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases
We present two cases of non-HIV, non-MS patients with PML who were treated with pembrolizumab with little clinical benefit. The literature surrounding pembrolizumab use in PML is discussed, with a focus on potential indicators of successful outcomes for patients who receive this therapy.
Source: Journal of NeuroVirology - Category: Neurology Source Type: research
More News: Autoimmune Disease | Brain | Cancer & Oncology | Multiple Sclerosis | Neurology | Rituxan | Study | Transplants | Tysabri